The tumor suppressor gene p16/MTS1, located on chromosome 9p21, is a c
ell cycle regulatory gene which is frequently altered in human cancers
, The role of this gene in prostate cancer is unknown, To determine th
e frequency of deletions and point mutations of p16/MTS1 in human pros
tate cancer, we examined 18 cancer and matched benign and hyperplastic
tissue specimens, Deletions of p16/MTS1 were detected by semi-quantit
ative multiplex polymerase chain reaction in which a portion of exon 2
of the p16/MTS1 gene and a control marker, the glyceraldehyde 3-phosp
hate dehydrogenase gene, were amplified simultaneously, 'Cold' single-
stranded conformational polymorphism (SSCP) analysis was performed to
examine exons 1 and 2 of the p16/MTS1 gene for point mutations, Our da
ta indicate no evidence for intragenic homozygous deletion in the pros
tate tumors, One prostate tumor and matched benign tissue showed mobil
ity shifts, Direct DNA sequencing of the SSCP positive samples showed
a G --> A transition in codon 140 which would result in an amino acid
change from alanine to threonine, Our results indicate that deletions
and point mutations in the p16/MTS1 gene are rare and do not play a ma
jor role in human prostate carcinogenesis.